Saturday, October 24, 2020
Pharma Pharma News

Latest articles in Pharma News

Purdue Reformulated OxyContin to Reduce Abuse — Did They Succeed?

OxyContin was neither superior to old-fashioned immediate-release oxycodone, a cheaper generic, nor did it offer any advantage over other opioids like morphine.

Free Drive-thru Flu Shot Clinics Across Los Angeles County

L.A. Care Health Plan and Blue Shield of California Promise Health Plan's network of Community Resource Centers are offering drive-thru flu shot clinics across Los Angeles County

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

TaiGen files US IND for its influenza antiviral TG-1000

TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

The new drug program aims to decrease the amount of UTIs that would otherwise require antibiotic intervention.

Lilly commits Insulin Value Program, With $35 Copay Card

Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.

Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells

An experimental compound prevents the virus that causes COVID-19 from entering human airway cells, a new study finds.

The Diversion of Drugs Within Healthcare Needs to be Addressed

The Protenus Drug Diversion Digest found that over half of diversion incidents took place in a hospital, medical center, or physician practice setting

Trials Validate Cognition Improvement Using PrimeMyBody Hemp Extract

Clinical brain mapping screenings of former NFL players who suffer from cognitive deficits provide supportive data that PrimeMyBody's FOCUS Mind & Body Hemp Extract improved brain performance for 80 percent of screening participants

FDA grants yet another EUA for RNA Extraction-Free Covid-19 Assay

A SARS-CoV-2 diagnostic test which eliminates the costly and time-consuming step of RNA extraction. As opposed to most other molecular assays that rely on RNA extraction and qRT-PCR

Doctors Find Drug for Lethal Lung Disease After Decades of Trying

An international team of researchers reports in the New England Journal of Medicine dramatically transforming aPAP treatment by helping develop a drug that patients can inhale once a day so their body will clear out the pulmonary waste.

Drug Shortages During the Time of Coronavirus

An astonishing 82% of drug shortages are listed as reason unknown. The other causes include manufacturing, discontinuation, raw materials, and supply and demand.

Editors Choice

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

Trials Validate Cognition Improvement Using PrimeMyBody Hemp Extract

Clinical brain mapping screenings of former NFL players who suffer from cognitive deficits provide supportive data that PrimeMyBody's FOCUS Mind & Body Hemp Extract improved brain performance for 80 percent of screening participants

Drug Shortages During the Time of Coronavirus

An astonishing 82% of drug shortages are listed as reason unknown. The other causes include manufacturing, discontinuation, raw materials, and supply and demand.